Clinical Updates

Covid Phase

April 3, 2024

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease |
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs |
Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases

April 3, 2024 Read More »

Covid Treatment

March 28, 2024

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment – A Randomized Clinical Trial | Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach | Timing and Predictors of Loss of Infectivity Among Healthcare Workers with Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study |
Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study

March 28, 2024 Read More »

Covid Oximeter

March 21, 2024

Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial |
Prevalence of Orthostatic Intolerance in Long COVID Clinic Patients and Healthy Volunteers: A Multicenter Study | Autonomic Cardiac Function in Children and Adolescents with Long COVID: A Case-controlled Study | Iron Dysregulation and Inflammatory Stress Erythropoiesis Associates with Long-term Outcome of COVID-19

March 21, 2024 Read More »

Comparative study findings

March 14, 2024

Vaccine Effectiveness Against Long COVID in Children | Impact of Vaccination on the Association of COVID-19 with Cardiovascular Diseases: An OpenSAFELY Cohort Study | The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

March 14, 2024 Read More »

COVID: Active Vaccination/Immunity

March 7, 2024

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults |
Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform |
Cognition and Memory after COVID-19 in a Large Community Sample |
Prospective Memory Assessment Before and After Covid-19 |
What is the Impact of Long-term COVID-19 on Workers

March 7, 2024 Read More »

Compilation of studies

February 29, 2024

Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals |
Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition

February 29, 2024 Read More »

Graph comparing

February 22, 2024

Self-administered versus Clinician-performed BinaxNOW COVID Rapid Test: A Comparison of Accuracy |
The Impact of COVID-19 Vaccination Prior to SARS-CoV-2 Infection on Prevalence of Long COVID among a Population-based Probability Sample of Michiganders, 2020-2022 |
Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection |
Long-term risks of Respiratory Diseases in Patients Infected with SARS-CoV-2

February 22, 2024 Read More »

Research findings on RSV and flu vaccines

February 15, 2024

Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission |
Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination |
Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease |
Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease

February 15, 2024 Read More »

Mother with her newborn baby at the hospital in front of a window

February 8, 2024

Estimating the Heritability of SARS-CoV-2 Susceptibility and COVID-19 Severity | Neonatal Outcomes After COVID-19 Vaccination in Pregnancy | Contralateral Second Dose Improves Antibody Responses to a Two-dose mRNA Vaccination
Regimen | Substantial Health and Economic Burden of COVID-19 During the Year After Acute Illness
Among US Adults Not at High Risk of Severe COVID-19

February 8, 2024 Read More »

Mature man holding his shirt sleeve up while wearing mask as doctor administers vaccine in upper arm

January 31, 2024

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons | Effectiveness of High-dose vs. Standard-dose Quadrivalent Influenza Vaccine against Recurrent Hospitalizations and Mortality in Relation to Influenza Circulation: A Post-hoc Analysis of the DANFLU-1 Randomized Clinical Trial

January 31, 2024 Read More »

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

¡Done a los Parásitos Sin Fronteras hoy!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio